Literature DB >> 11891037

Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis.

Hans-Jurgen Mager1, Boudewijn Maesen, Fred Verzijlbergen, Franz Schramel.   

Abstract

Talc pleurodesis is an effective technique for the management of symptomatic malignant pleural effusions. It is assumed that a good dispersion of talc suspension contributes to the final success of this treatment. For this purpose, guidelines often advise to rotate the patient after intra-pleural instillation of the sclerosant. This prospective, randomized study analyses the dispersion of talc suspension and the overall success rate in patients with malignant effusions. After instillation of 99mTc-sestamibi-labeled talc suspension ten subjects were rotated for 1 h, while the ten other patients remained in a stable supine body position. Scintigraphic imaging was done in two directions immediately after instillation and after 1 h with a clamped drain. The overall success of the treatment was assessed 1 month after the pleurodesis. The dispersion of talc was limited and unequal in 75% of the subjects. In two patients with apparently good distribution on anterior views, the lateral views of the scintigraphy showed only limited distribution. Rotation of the patients did not influence the dispersion of sludge after 1 min or 1 h. Pleurodesis was successful in 85% of the patients after 1-month follow-up. Standard rotation protocols for patients with malignant pleural effusion do not affect the overall dispersion of talc suspension and should be abolished because of the discomfort caused to the patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891037     DOI: 10.1016/s0169-5002(01)00475-5

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

2.  Management of pleural effusion, empyema, and lung abscess.

Authors:  Hyeon Yu
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 3.  Current best practice in the evaluation and management of malignant pleural effusions.

Authors:  Steven Walker; Anna C Bibby; Nick A Maskell
Journal:  Ther Adv Respir Dis       Date:  2016-10-24       Impact factor: 4.031

Review 4.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis.

Authors:  P D'Agostino; A Rao Camemi; R Caruso; F Arcoleo; A Cascio; A Dolce; E Sacco; G Cangemi; T di Rosa; P Moceo; E Cillari
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 6.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 7.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08

8.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Alexandra Dipper; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell; Amelia O Clive
Journal:  Cochrane Database Syst Rev       Date:  2020-04-21

9.  Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis.

Authors:  Srinivas Mummadi; Anusha Kumbam; Peter Y Hahn
Journal:  F1000Res       Date:  2014-10-27

Review 10.  Pleural procedures in the management of malignant effusions.

Authors:  Lucía Ferreiro; Juan Suárez-Antelo; Luis Valdés
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.